Dr. Dana Lambert is the founder & CEO of Andira Pharmaceuticals, a cannabinoid-focused biopharmaceutical company dedicated to solving antimicrobial resistance (AMR) and transforming cancer treatment globally. Dr. Lambert is responsible for the invention and development of five therapeutic and medical device products in Andira Pharmaceuticals’ pipeline, having over 20 patents pending globally, a US patent granted, multiple scientific publications and several research awards in pharmaceutical science. She holds a PhD in Pharmaceutical Sciences from the University of British Columbia, Vancouver, Canada and started her career as a hospital pharmacist and healthcare executive.